Cystic Fibrosis (CF) is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Relative to wild type CFTR, the most common mutation deltaF508-CFTR, present in >85% of CF patients is expressed at low levels in the plasma membrane and has reduced in vivo activity. Thus to correct the deltaF508-CFTR mutation both the number of plasma membrane channels and the activity of individual channels must be increased. Our data suggest that the reduced in vivo activity of deltaF508 - CFTR is due to a reduced level of phosphorylation. In this study we will test two hypotheses, 1) that differences in CFTR activity can be caused by differences in channel phosphorylation, and 2) that differences in the activity of wild type and deltaF508-CFTR are due to differences in phosphorylation. By activating CFTR under various experimental conditions and by examining CFTR with serine to alanine mutations at phosphorylation sites, we will generate CFTR with different phosphorylation states. Then by comparing the channel kinetics of different phosphorylation states, we will generate structure function relationships. Our studies will provide. biochemical evidence for the hypotheses that PKC-dependent phosphorylation is required for PKA-dependent activation and that protein phosphatases show selectivity with respect sites of dephosphorylation. These studies will assist in the development of drugs to treat CF patients with deltaF508-CFTR.
In specific aim I, two-dimensional peptide mapping, site-directed mutagenesis and mass spectroscopy will be used to identify sites of PKC- and PKA-dependent CFTR phosphorylation and establish experimental conditions where CFTR phosphorylation differs.
In specific aim II, channel kinetic parameters will be determined for CFTR that has been phosphorylated on different sites. Alterations in mean open and closed times, Po and the number of active channels will be correlated with phosphorylation at specific sites.
In specific aim III, we will compare phosphorylation and channel kinetics of wild type and deltaF508-CFTR to determine if differences in channel activity are correlated with differences in phosphorylation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL070563-02
Application #
6538132
Study Section
Medical Biochemistry Study Section (MEDB)
Program Officer
Banks-Schlegel, Susan P
Project Start
2001-09-20
Project End
2005-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
2
Fiscal Year
2002
Total Cost
$317,000
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104